JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruitenbeek, W.
Right arrow Articles by Gabreels, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruitenbeek, W.
Right arrow Articles by Gabreels, F. J.

Journal of Neurology, Neurosurgery, and Psychiatry, 1995, Vol 58, 209-214

PAPERS

Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl- CoA dehydrogenase deficiency

W Ruitenbeek, PJ Poels, DM Turnbull, B Garavaglia, RA Chalmers, RW Taylor and FJ Gabreels
Department of Pediatrics, University Hospital Nijmegen, The Netherlands.

A previously asymptomatic 30 year old man presented with rhabdomyolysis, muscle weakness, and acute encephalopathy after strenuous exertion in the cold without adequate food intake. Serum and muscle carnitine concentrations were decreased. Urinary excretion of carnitine and glycine esters and biochemical examination of skeletal muscle and fibroblasts led to the diagnosis of medium chain acyl-CoA dehydrogenase (MCAD) deficiency. A point mutation at nucleotide position 985 of the coding region of the MCAD gene was found. The MCAD protein was synthesised in the patient's fibroblasts at a normal rate, but was unstable. In general, patients in whom the 985 point mutation has been established show much more severe clinical symptoms and other symptoms than those seen in this patient. The relation of the 985 point mutation and the residual MACD activity to the symptoms is not as straightforward as previously thought.

© 1995 by Journal of Neurology, Neurosurgery, and Psychiatry



This article has been cited by other articles:


Home page
 JAMAHome page
S. E. Waisbren and H. L. Levy
Expanded Screening of Newborns for Genetic Disorders
JAMA, February 18, 2004; 291(7): 820 - 821.
[Full Text] [PDF]

Home page
 PediatricsHome page
A. S. Hollander, R. C. Olney, P. R. Blackett, and B. A. Marshall
Fatal Malignant Hyperthermia-Like Syndrome With Rhabdomyolysis Complicating the Presentation of Diabetes Mellitus in Adolescent Males
Pediatrics, June 1, 2003; 111(6): 1447 - 1452.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. Y. Wang, S. Kannan, D. Shay, S. Segal, S. Datta, and L. Tsen
Anesthetic Considerations for a Patient with Compound Heterozygous Medium-Chain Acyl-CoA Dehydrogenase Deficiency
Anesth. Analg., June 1, 2002; 94(6): 1595 - 1597.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1995 by the BMJ Publishing Group Ltd.